Could your own immune cells fight ovarian cancer? tiny trial aims to find out
Disease control
Recruiting now
This early-stage trial is testing whether a patient's own tumor-fighting immune cells (called TILs) can be safely used to treat recurrent ovarian cancer. Researchers take a sample of the tumor, grow the immune cells in a lab, and then inject them back into the patient. Only 6 peo…
Phase: NA • Sponsor: Yong Wha Moon • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC